LONG TERM Outcomes of Pediatric Patients with Malignant and NON-Malignant Disorders Receiving Α/Β T-CELL Depleted HLA-Haploidentical Hematopoietic STEM CELL Transplantation (HSCT) Followed by Infusion of BPX-501 T CELLS (DONOR T CELLS Transduced with IC9
Swati Naik(St. Jude Children's Research Hospital), Franco Locatelli(Bambino Gesù Children's Hospital), Waseem Qasim(University College London), Ann E. Woolfrey(University of Washington), Kris M. Mahadeo(Duke University), Susanne H.C. Baumeister(Dana-Farber Cancer Institute), Mary Slatter(First Pavlov State Medical University of St. Petersburg), Alice Bertaina(Stanford University), Victor Aquino(The University of Texas Southwestern Medical Center), Neena Kapoor(University of Southern California), Annemarie Moseley(Bellicum Pharmaceuticals (United States)), Eneida R. Nemecek(Oregon Health & Science University)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
Evidence for 28 genetic disorders discovered by combining healthcare and research data
|Nature|2020|672
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577